Other authors have already reported that the imbalance in IL-13 receptors is the key feature for changing IL-13 signaling in other animal models of PAH and in patients with idiopathic PAH, more than changes in circulating levels of this cytokine [40,41]. The gene discussed is IL13; the disease is pulmonary arterial hypertension.